User login

Enter your username and password here in order to log in on the website:

Forgot your password?


Regulatory Announcement: Dr Bartl Wimmer to retire as SYNLAB Group CEO in April 2018 Deputy CEO Mathieu Floreani to succeed as Group CEO from 2 April 2018

Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 April 2018. He will remain with the Group as a Senior Advisor, a Director of the SYNLAB Board and as a significant shareholder.

Mathieu Floreani, who joined the Group as Deputy CEO in 2017, will succeed Dr Bartl Wimmer as Group CEO with effect from 2 April 2018. Dr Wimmer will work closely with Mr Floreani until the end of June to effect a seamless transition.